Published in J Virol on May 12, 2016
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 17.54
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods (2003) 11.81
HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol (2004) 5.18
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A (1984) 4.97
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A (2006) 3.11
Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol (2012) 3.03
Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet (1990) 2.96
The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology (2005) 2.62
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol (1991) 2.27
Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest (2013) 2.06
Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer (2004) 2.04
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology (1992) 1.94
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res (1992) 1.79
Vaccine-induced CD8+ T cells control AIDS virus replication. Nature (2012) 1.78
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. Blood (2015) 1.56
CTL quality and the control of human retroviral infections. Eur J Immunol (2009) 1.50
Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol (2012) 1.46
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia (2003) 1.39
Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology (2004) 1.32
Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology (1994) 1.28
Therapeutic cancer vaccines. J Clin Invest (2015) 1.23
Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci (2001) 1.19
HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Front Microbiol (2012) 1.16
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene (2005) 1.15
Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol (2009) 1.14
Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res (2004) 1.12
Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr (1999) 1.09
High prevalence of simian T-lymphotropic virus type L in wild ethiopian baboons. J Virol (2002) 1.09
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis (2004) 1.04
Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses (2000) 1.01
Molecular epidemiology of HTLV-I in the world. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.01
HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol (2009) 1.00
The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci (Landmark Ed) (2009) 1.00
Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries. Int J Cancer (1987) 0.98
Interspecies transmission of macaque simian T-cell leukemia/lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J Virol (1996) 0.96
Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs. J Immunol (2007) 0.95
HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses (2001) 0.94
Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol (2008) 0.93
Evolutionary inferences of novel simian T lymphotropic virus type 1 from wild-caught chacma (Papio ursinus) and olive baboons (Papio anubis). Virology (1998) 0.91
Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. Blood (1997) 0.91
Transmission dynamics of simian T-lymphotropic virus type 1 (STLV1) in a baboon breeding colony: predominance of female-to-female transmission. Comp Med (2007) 0.90
Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci (1993) 0.89
Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection. J Virol (2010) 0.89
Origin of HTLV-1 in hunters of nonhuman primates in Central Africa. J Infect Dis (2014) 0.89
High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys. Int J Cancer (2003) 0.89
Simian T-cell lymphotropic Viruses (STLVs) and lymphomas in African nonhuman primates. Cancer Invest (2001) 0.89
Development of a generic real-time PCR assay for simultaneous detection of proviral DNA of simian Betaretrovirus serotypes 1, 2, 3, 4 and 5 and secondary uniplex assays for specific serotype identification. J Virol Methods (2009) 0.89
Molecular characterization and phylogenetic analyses of a new simian T cell lymphotropic virus type 1 in a wild-caught african baboon (Papio anubis) with an indeterminate STLV type 2-like serology. AIDS Res Hum Retroviruses (2000) 0.87
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br J Haematol (2015) 0.87
Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases. Viruses (2015) 0.86
Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection. Retrovirology (2013) 0.85
Multiplexed fluorometric immunoassay testing methodology and troubleshooting. J Vis Exp (2011) 0.84
Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. J Med Virol (2007) 0.84
Mortality in captive baboons (Papio spp.): a-23-year study. J Med Primatol (2014) 0.84
Dynamic interaction between STLV-1 proviral load and T-cell response during chronic infection and after immunosuppression in non-human primates. PLoS One (2009) 0.83
Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol (2006) 0.82
Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression. Retrovirology (2014) 0.82
The tax gene sequences form two divergent monophyletic lineages corresponding to types I and II of simian and human T-cell leukemia/lymphotropic viruses. Virology (1997) 0.81
Simultaneous detection of antibodies to five simian viruses in nonhuman primates using recombinant viral protein based multiplex microbead immunoassays. J Virol Methods (2011) 0.81
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection. J Virol (2015) 0.80
A vaccine against HTLV-1 HBZ makes sense. Blood (2015) 0.79
Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. J Clin Immunol (2012) 0.79
Simian T-lymphotropic Virus-associated lymphoma in 2 naturally infected baboons: T-cell clonal expansion and immune response during tumor development. Comp Med (2013) 0.78
The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan. Leuk Lymphoma (2015) 0.76
Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys. Mol Ther (2015) 0.83
Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239. J Virol (2014) 0.82
Potent Plasmablast-Derived Antibodies Elicited by the NIH Dengue Vaccine. J Virol (2017) 0.75
STLV-1 infection of Papio Anubis: tax Sequence Heterogeneity and T Cell Recognition. J Virol (2017) 0.75